Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas. |
|
Press Release - Accuray Incorporated (ARAY-NASDAQ) |
|
|
“If you are a patient, you should remember that Accuray’s CyberKnife is an alternative to surgery. It’s a non-invasive, painless out-patient procedure. The Cyberknife can treat inoperable tumors, and even if operable, you don’t want to cut open the patient, crack open their rib cage, and deflate their lungs in order to treat a lung tumor or invasively treat a tumor that is wrapped around the spine. It may be inoperable in that case. Our technology offers the means to deliver high doses of radiation...” - Robert E. McNamara (ARAY) (Interview published May 30, 2008) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | SERVICES | HOME PAGE |
|
First Patients Treated in India Using
CyberKnife Radiosurgery
Newly Installed System at Apollo Hospital Treats Six and Preps Eight Patients in First Week "Our new CyberKnife System allows us to deliver highly precise
radiosurgical treatments to patients with tumors throughout the
body," said Prathap C. Reddy, M.D., executive chairman, The CyberKnife treatment team at "Since India is the second most populous nation in the world, we
are excited that CyberKnife radiosurgery is now an option for its
population and that the first patients have received treatment,"
said Advanced Medical Systems (headquartered in About It was in 1983 that Dr. Prathap Reddy made a pioneering endeavor
by launching India's first corporate hospital - About the CyberKnife(R) Robotic Radiosurgery System The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames. About Safe Harbor Statement The foregoing may contain certain forward-looking statements that
involve risks and uncertainties, including uncertainties associated
with the medical device industry. Except for the historical
information contained herein, the matters set forth in this press
release, including statements relating to commercialization of
products, regulatory review and approval and clinical studies are
forward-looking statements within the meaning of the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements speak only as of the date the statements
are made and are based on information available at the time those
statements are made and/or management's good faith belief as of that
time with respect to future events. You should not put undue
reliance on any forward-looking statements. Important factors that
could cause actual performance and results to differ materially from
the forward-looking statements we make include: market acceptance of
products; competing products, the combination of our products with
complementary technology; and other risks detailed from time to time
under the heading "Risk Factors" in our report on Form 10-K for the
2008 fiscal year, as updated in our Form 10-Q filed on SOURCE CONTACT:
|
ceocfointerviews.com does not purchase or
make
recommendation on stocks based on the interviews published.